Events

Past Event

Thesis Defense In Chemistry, Presented by Baiyu Qiu

January 29, 2024
1:00 PM - 2:00 PM
Event time is displayed in your time zone.
700 Fairchild

Discovery of Unusual Phospholipids as Ferroptosis Markers

Presented By: Baiyu Qiu

 

Abstract:
Ferroptosis, an oxidative cell death mechanism, is driven by iron-dependent lipid peroxidation. Despite being generally associated with lipid peroxidation that overwhelms endogenous repair systems, ferroptosis mechanisms and regulators in various pathological contexts remain elusive. Identifying novel modulators of the ferroptosis pathway is essential for cell-death marker development and drug discovery to target this process. Small molecule drugs and dietary intervention of metabolites and lipids can modulate ferroptosis sensitivity in diverse disease contexts.

In this thesis, I investigated lipid metabolism involving ferroptosis in cancer models and infectious lung disease model. I dissected the different roles of PUFA-containing phospholipids in dietary modulation of ferroptosis and discovered a specific phospholipid class, phosphatidylcholine with diacyl-polyunsaturated fatty acid tails (PC-PUFA 2 ; diacyl-PUFA-PC) that promote ferroptosis. Exogenous PC-PUFA 2 or free PUFA enriched PC-PUFA 2 abundance in cancer cells and accounted for the ferroptosis-sensitizing effects. I also discovered the accumulation of PC-PUFA 2 in the mitochondria, which disrupts mitochondrial redox homeostasis and initiates lipid peroxidation in the endoplasmic reticulum. These findings unveil the essential roles of diacyl-PUFA phospholipids during ferroptosis.

Utilizing biomarkers of ferroptosis, I studied pathogenic mechanism of COVID-19 associated pulmonary diseases. Elevated ferroptosis markers including transferrin receptor 1 and lipid peroxidation products were detected in human COVID-19 lung autopsies. Iron metabolism is affected in COVID-19 lung and is associated with ferroptosis activation. We further discovered strong correlation of ferroptosis markers with lung injury severity in a COVID-19 model using Syrian hamster. These findings provide the fundament for targeting ferroptosis as a novel therapeutic and diagnostic strategy for various diseases.

 

Contact Information

(212) 854-2202